Publisher and editorial responsibility
Who publishes PeptideScanner
GoodSir Labs publishes PeptideScanner and is responsible for the topics selected, the wording presented here, and the corrections attached to public records.
What PeptideScanner offers
PeptideScanner is a selective index of public peptide records. The current beta contains 41 source-linked profiles, 15 dated updates, and 54 cited records. It helps readers move from a peptide or related product name to attributable label, trial, regulatory, and safety material.
How editorial responsibility works
Representatives from GoodSir Labs choose topics and sources, review the language published under the PeptideScanner name, and approve visible corrections. Sources do not approve our summaries. Vendors cannot pay for inclusion, ranking, or favorable wording.
Software checks identities, dates, citations, and public-data boundaries. AI tools may assist with research, extraction, and editing, but they do not independently decide what is true or publish content. Read the editorial methodology and automation disclosure.
How to inspect or challenge the work
Every factual profile and update points to its supporting public records. Material changes retain version history and a dated notice. The source register describes current coverage and gaps, while the changes and corrections page records public changes.
PeptideScanner does not yet publish a dedicated organization-level reporting channel. A verified GoodSir Labs route will be added before the site invites submissions; no personal contact details are exposed in the meantime.
Machine-readable access
Search engines and agents can use the RSS update feed, the versioned public data projection, AI navigation file, and canonical XML sitemap. These surfaces contain only the same reviewed public material available on the website.